Latest filing published 04 Jan 2017 for ARGOS THERAPEUTICS INC.
Insider track record
No signal scores available.
Igor Krol: trading record in brief
All filings by Igor Krol on record concern Argos Therapeutics Inc. Over a trading history stretching from 30 June 2016 to 31 December 2016, the count stands at 3 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 4 January 2017: a share grant, in Argos Therapeutics Inc. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Igor Krol
Open company profiles for insider transactions, fundamentals and analyst consensus when available.